Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Certara, Inc.
  6. Summary
    CERT   US15687V1098

CERTARA, INC.

(CERT)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
12.92 USD   -1.07%
09/14TRANSCRIPT : Certara, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-14-2022 12:15 PM
CI
09/13TRANSCRIPT : Certara, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:45 AM
CI
09/08Berenberg Bank Initiates Certara at Buy Rating, $23 Price Target
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/19/2022 09/20/2022 09/21/2022 09/22/2022 09/23/2022 Date
14.07(c) 13.42(c) 13.22(c) 13.06(c) 12.92(c) Last
767 000 792 200 718 521 815 327 875 558 Volume
-0.99% -4.62% -1.49% -1.21% -1.07% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 331 M - -
Net income 2022 6,77 M - -
Net Debt 2022 37,7 M - -
P/E ratio 2022 497x
Yield 2022 -
Sales 2023 377 M - -
Net income 2023 22,5 M - -
Net cash position 2023 65,1 M - -
P/E ratio 2023 124x
Yield 2023 -
Capitalization 2 066 M 2 066 M -
EV / Sales 2022 6,36x
EV / Sales 2023 5,30x
Nbr of Employees 1 084
Free-Float 95,6%
More Financials
Company
Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. The Company builds its biosimulation technology on the first principles of biology, chemistry, and pharmacology with mathematical algorithms that model how... 
Sector
Software
Calendar
11/08Earnings Release
More about the company
Ratings of Certara, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CERTARA, INC.
09/14TRANSCRIPT : Certara, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-14-202..
CI
09/13TRANSCRIPT : Certara, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Confer..
CI
09/08Berenberg Bank Initiates Certara at Buy Rating, $23 Price Target
MT
08/31Certara to Participate in Upcoming Investor Conferences
GL
08/25Credit Suisse Initiates Certara at Outperform with $22 Price Target
MT
08/24Morgan Stanley Adjusts Certara's Price Target to $20 from $24, Maintains Equalweight Ra..
MT
08/23INSIDER BUY : Certara
MT
08/18INSIDER BUY : Certara
MT
08/18INSIDER SELL : Certara
MT
08/17INSIDER SELL : Certara
MT
08/17Barclays Adjusts Certara's Price Target to $21 From $24, Reiterates Overweight Rating
MT
08/15CERTARA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/12CERTARA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
08/12Certara, Inc. Announces Resignation of Justin Edge as President of Regulatory and Acces..
CI
08/12SECTOR UPDATE : Health Care Stocks Extending Friday Recovery
MT
More news
News in other languages on CERTARA, INC.
08/23ACHAT D'INITIÉS : Certara
08/18ACHAT D'INITIÉS : Certara
08/12Certara, Inc. annonce la démission de Justin Edge en tant que président de la réglement..
08/12MISE À JOUR SECTORIELLE : Les actions du secteur de la santé prolongent la reprise de vend..
08/12MISE À JOUR SECTORIELLE : Les actions du secteur de la santé contribuent à la hausse du ma..
More news
Analyst Recommendations on CERTARA, INC.
More recommendations
ETFs positioned on CERTARA, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares Morningstar Small-Cap Growth ETF - USD0.14%-7.25%-NC
Lyxor MSCI Digital Economy ESG Filtered (DR...0.14%-5.27%-World
IShares Morningstar Small-Cap ETF - USD0.07%-5.97%-NC
IShares Russell Mid-Cap Growth ETF - USD0.05%-6.45%United_States
IShares U.S. Healthcare ETF - USD0.05%-3.49%-NC
More ETFs positioned on CERTARA, INC.
Chart CERTARA, INC.
Duration : Period :
Certara, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CERTARA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 12,92 $
Average target price 23,31 $
Spread / Average Target 80,4%
EPS Revisions
Managers and Directors
William F. Feehery Chief Executive Officer & Director
Michael Andrew Schemick Chief Financial Officer
James E. Cashman Chairman
Eric C. Liu Independent Director
Stephen M. McLean Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CERTARA, INC.-54.54%2 066
MICROSOFT CORPORATION-28.35%1 774 382
ATLASSIAN CORPORATION PLC-42.94%55 465
SYNOPSYS INC.-17.70%46 375
DASSAULT SYSTÈMES SE-33.08%44 727
CADENCE DESIGN SYSTEMS, INC.-13.62%44 085